Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Sarcoma Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Immune Disease,
Leukocyte Adhesion Deficiency
Adult Stem Cell Gene-modified, personalized cell therapy Rocket Pharmaceuticals, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Type 1 diabetes Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Cystinosis,
Kidney Failure
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer,
Breast Cancer
Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Age-related macular degeneration Embryonic Stem Cell Biologic USC
Pre-IND/IDE or Equivalent
Traumatic Brain Injury Embryonic Stem Cell Donor cell therapy UC Irvine
Pre-IND/IDE or Equivalent
Spinal Cord Injury Embryonic Stem Cell Donor cell therapy UCSD
Pre-IND/IDE or Equivalent
Brain Injury, hypoxic, ischemic Adult Stem Cell Donor cell therapy Sanford-Burnham
Pre-IND/IDE or Equivalent
IPEX Syndrome,
Immune Disease
Vital Research Opportunity Gene Therapy, cell free Stanford
IND
Retinitis Pigmentosa Therapeutic Approach jCyte
Clinical Trial, Phase 2
Retinitis Pigmentosa Adult Stem Cell Donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Corneal Damage Adult Stem Cell Personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Parkinson's Disease Vital Research Opportunity Gene Therapy, cell free Brain Neurotherapy Bio
Clinical Trial, Phase 1 or Phase 1/2
Hyper IgM Syndrome,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Ovarian Cancer Adult Stem Cell Gene-modified, donor cell therapy COH
Pre-IND/IDE or Equivalent
Multiple Myeloma Adult Stem Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Embryonic Stem Cell Cell processing & handling Stanford
Research Insights
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy UCLA
Development Candidate, Proof of Concept
COVID-19,
Respiratory Disorders
Other,
Vital Research Opportunity
Convalescent Plasma COH
Research Insights
COVID-19 Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 2
Sickle Cell Disease Adult Stem Cell Donor cell therapy ExCellThera Inc.
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Proof of Concept
COVID-19 Adult Stem Cell Vaccine UCLA
Development Candidate, Proof of Concept
COVID-19 Adult Stem Cell Small molecule therapy UCLA
Pre-IND/IDE or Equivalent
COVID-19,
Respiratory Disorders
Adult Stem Cell Donor cell therapy Celularity Inc
Clinical Trial, Phase 1 or Phase 1/2
COVID-19,
Respiratory Disorders
iPS Cell Small molecule therapy Sanford-Burnham
Development Candidate, Proof of Concept
Epilepsy Embryonic Stem Cell Donor cell therapy Neurona Therapeutics
Research Insights
COVID-19,
Respiratory Disorders
Adult Stem Cell Biologic UCSD
Development Candidate, Proof of Concept
COVID-19 Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate, Proof of Concept
Severe Combined Immunodeficiency, X-linked (X-SCID) Adult Stem Cell Antibody Jasper Therapeutics, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Traumatic Brain Injury Embryonic Stem Cell Exosomes based therapy UC Irvine
Development Candidate, Proof of Concept, Research Insights
Skeletal/Smooth Muscle disorders Adult Stem Cell Small molecule therapy Stanford
Proof of Concept
HIV/AIDS,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease Adult Stem Cell Gene-modified, personalized cell therapy Rocket Pharmaceuticals, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Spina Bifida Adult Stem Cell Donor cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Ovarian Cancer iPS Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy Lundquist Institute
Development Candidate, Proof of Concept
Inflammatory bowel disease Adult Stem Cell Donor cell therapy Vitabolus, Inc.
Development Candidate, Proof of Concept
Neurological Disorders Embryonic Stem Cell Donor cell therapy UC Irvine
Development Candidate, Proof of Concept
Amyotrophic Lateral Sclerosis iPS Cell Nucleic acid based therapy USC
Development Candidate, Proof of Concept
Traumatic Brain Injury iPS Cell Donor cell therapy UC Irvine
Development Candidate, Research Insights
Stroke iPS Cell Donor cell therapy UCLA
Development Candidate, Proof of Concept
COVID-19 iPS Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
COVID-19 Embryonic Stem Cell,
iPS Cell
Gene-modified, donor cell therapy COH
Proof of Concept
Sickle Cell Disease Adult Stem Cell Gene-modified, personalized cell therapy Boston Children's Hospital
Clinical Trial, Phase 2
Spinal Cord Injury Embryonic Stem Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Research Insights
COVID-19 iPS Cell Model system development UC Berkeley
Proof of Concept
Beta Thalassemia,
Sickle Cell Disease
Adult Stem Cell Diagnostic Test UCSF
Regulated Lab Test, Ready for Validation

Pages

Icon for csv export